Talk:Antidepressant: Difference between revisions

>Brack
psilocybin explanation
>RobProduces
 
(6 intermediate revisions by 4 users not shown)
Line 2: Line 2:


==Types of antidepressants==
==Types of antidepressants==
===Serotonergics===
===Serotonin reuptake inhibitors===
====Serotonin reuptake inhibitors====
[[Dextromethorphan]]<ref>http://www.sciencedirect.com/science/article/pii/S0306987711000545</ref>
[[Dextromethorphan]]<ref>http://www.sciencedirect.com/science/article/pii/S0306987711000545</ref>
Because dextromethorphan can show similar antidepressant effects to ketamine in threshold and light dosages, it is possible that dextromethorphan could be a possible treatment for treatment resistant and severe depression. Many users of dextromethorphan claim that they do not feel any depression within a week of using dextromethorphan.{{citation needed}} It has a very similar mechanism of action to SSRIs. It is also useful for anxiety.
Because dextromethorphan can show similar antidepressant effects to ketamine in threshold and light dosages, it is possible that dextromethorphan could be a possible treatment for treatment resistant and severe depression. Many users claim that a single use of dextromethorphan alleviates their depression for up to a week.{{citation needed}} This may be a related to its activity as a reuptake inhibitor of serotonin. However, it is believed to have neurotoxic properties so its routine use as an antidepressant is not advised.
====Selective serotonin reuptake inhibitors ([[SSRIs]])====
===Selective serotonin reuptake inhibitors ([[SSRIs]])===
:Selective serotonin reuptake inhibitors are believed to increase the level of extracellular [[serotonin]], therefore allowing more serotonin to be in the brain. The reason SSRIs are used for depression is that the serotonin hypothesis, one of the most commonly accepted theories for depression, states that low serotonin in the brain causes depression. SSRIs are the most commonly prescribed antidepressant, and the most commonly prescribed anxiolytic for children. They are also the first-line treatment for panic disorder, not benzodiazepines like lorazepam and alprazolam.
Selective serotonin reuptake inhibitors are believed to increase the level of extracellular [[serotonin]], therefore allowing more serotonin to be in the brain. The reason SSRIs are used for depression is that the serotonin hypothesis, one of the most commonly accepted theories for depression, states that low serotonin in the brain causes depression. SSRIs are the most commonly prescribed antidepressant, and the most commonly prescribed anxiolytic for children. They are also the first-line treatment for panic disorder, not benzodiazepines like lorazepam and alprazolam.
====Selective serotonin reuptake enhancers (SSREs)====
===Serotonin-norepinephrine reuptake inhibitor (SNRIs)===
====Serotonin-norepinephrine reuptake inhibitor (SNRIs)====
Serotonin-norepinephrine reuptake inhibitors increase the level of extracellular [[serotonin]] and [[norepinephrine]], allowing more of the neurotransmitters to be in the brain. SNRIs are used for depression because the serotonin hypothesis states that low serotonin in the brain causes depression, and also to treat tiredness commonly experienced with depression.
====Serotonin modulators and stimulators (SMSes)====
===Serotonin modulators and stimulators (SMSes)===
====Serotonin antagonists and reuptake inhibitors (SARIs)====
===Serotonin antagonists and reuptake inhibitors (SARIs)===
====Serotonin releasing agents (SRAs)====
===Serotonin releasing agents (SRAs)===
These agents work by directly increasing the amount of serotonin in the brain. Substances such as [[cocaine]] and [[MDMA]] can do this, but both are addictive and tolerance quickly builds to each. Additionally, the MDMA "comedown" can produce weeks to months of a low mood and motivation if the user "rolls" (doses) frequently and suddenly stops.
The psychoactive effects caused by these agents can be mainly attributed to their mechanism of action by inducing release of [[serotonin]] into the neuronal synaptic cleft. Causing an increased concentration and availability of serotonin in the brain. Even though drugs such as MDMA can be technically referred to as SRA’s, it’s however more accurate classification would be an SNDRA over an SRA. Since unlike Selective serotonin releasing agents (SSRA’s) such as [[PMA]] (common cutting agent used for MDMA) which only effects serotonin release, MDMA also induces the release of both dopamine and norepinephrine. It should be noted that PMA and other SSRA’s/SRA’s alike are typically not considered to be reinforcing(addictive) as they lack appreciable dopaminergic and [[adrenergic]] activity. On the other hand substances such as [[Methamphetamine]] and [[MDMA]] are addictive In nature due to their euphoric action on dopamine which is further amplified through their secondary role as SRA’s. FYI Methamphetamine is a very weak SRA so you most likely see it called an [[NDRA]] (Norepinephrine/dopamine releasing agent) over an [[SNDRA]].
 
===Norepinephrine reuptake inhibitors (NRIs)===
===Norepinephrine reuptake inhibitors (NRIs)===
:NRIs are believed to increase the level of extracellular [[norepinephrine]], therefore allowing more of it to be in the brain. Controversy has been sparked over the effectiveness of reboxetine, an NRI sold as Trintellix. <ref>"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis." Multiple authors (2009) https://www.researchgate.net/profile/Andrea_Cipriani/publication/23967068_Comparative_efficacy_and_acceptability_of_12_new-generation_antidepressants_A_multiple-treatments_meta-analysis/links/00b7d5278b5bed4c17000000.pdf</ref>
:NRIs are believed to increase the level of extracellular [[norepinephrine]], therefore allowing more of it to be in the brain. Controversy has been sparked over the effectiveness of reboxetine, an NRI sold as Edronax. <ref>"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis." Multiple authors (2009) https://www.researchgate.net/profile/Andrea_Cipriani/publication/23967068_Comparative_efficacy_and_acceptability_of_12_new-generation_antidepressants_A_multiple-treatments_meta-analysis/links/00b7d5278b5bed4c17000000.pdf</ref> Norepinephrine reuptake inhibitors can treat the tiredness commonly experienced with depression.
 
===Norepinephrine-dopamine reuptake inhibitors (NDRIs)===  
===Norepinephrine-dopamine reuptake inhibitors (NDRIs)===  
:NDRIs are believed to increase the level of extracellular [[norepinephrine]] and [[dopamine]], therefore allowing more of these to be in the brain. Agents such as bupropion (Wellbutrin) have been found effective for MDD with little direct effect on serotonin, and therefore it can be hypothesized that other agents are effective for it. Bupropion and other NDRIs are also effective for depression with fatigue or sleepiness.
:NDRIs are believed to increase the level of extracellular [[norepinephrine]] and [[dopamine]], therefore allowing more of these to be in the brain. Agents such as bupropion (Wellbutrin) have been found effective for MDD with little direct effect on serotonin, and therefore it can be hypothesized that other agents are effective for it. Bupropion and other NDRIs are also effective for depression with fatigue or sleepiness.
Line 21: Line 22:
===Tetracyclic antidepressants (TeCAs)===
===Tetracyclic antidepressants (TeCAs)===
===Monoamine Oxidase Inhibitors ([[MAOI]]s)===
===Monoamine Oxidase Inhibitors ([[MAOI]]s)===
MAOIs are usually prescribed when no other antidepressants are helping. This is because MAOIs require diet changes and have a very large amount of side effects.<ref>http://www.mayoclinic.org/diseases-conditions/depression/in-depth/maois/art-20043992</ref>
MAOIs are usually prescribed when no other antidepressants are helping. This is because MAOIs require diet changes and have a very large amount of side effects. MAOIs mainly prevent the breakdown of monoamine neurotransmitters in the brain such as [[serotonin]], [[dopamine]], and [[norepinephrine]].<ref>http://www.mayoclinic.org/diseases-conditions/depression/in-depth/maois/art-20043992</ref>
 
==Experimental treatments==
===[[Psilocybin mushrooms]]===
Psilocybin and other classical psychedelics such as [[LSD]] have been researched as a treatment for depression and anxiety disorders. Studies have shown that psilocybin is highly effective in reducing overall depression and anxiety.{{citation needed}}


==Psychedelics for treating depression==
===[[Psilocybin mushrooms]] ("magic mushrooms")===
Psilocybin has been researched as a treatment for depression and anxiety, as well as end of life depression and anxiety. Studies have shown that psilocybin is extremely effective in reducing overall depression and anxiety.
===[[Ketamine]]===
===[[Ketamine]]===
In clinical studies, ketamine has proven to be an extremely effective and fast acting antidepressant at low doses (compared to common recreational doses).<ref>https://www.nimh.nih.gov/about/strategic-planning-reports/highlights/highlight-ketamine-a-new-and-faster-path-to-treating-depression.shtml</ref> It has become increasingly common for doctors to prescribe ketamine for treatment-resistant and severe depression.  
In clinical studies, ketamine has proven to be an extremely effective and fast acting antidepressant at low doses (compared to common recreational doses).<ref>https://www.nimh.nih.gov/about/strategic-planning-reports/highlights/highlight-ketamine-a-new-and-faster-path-to-treating-depression.shtml</ref> It has become increasingly common for doctors to prescribe ketamine for treatment-resistant depression, severe depression, and addiction.
===[[LSD]]===
 
{{citation needed}}
==External links==
*[[wikipedia:Antidepressant|Antidepressant (Wikipedia)]]


==References==
==References==
[[Category:Articles in talk page]]
[[Category:Articles in talk page]]
Return to "Antidepressant" page.